Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.340 SomaticCausalMutation ORPHANET Preoperative RAS mutational analysis is of great value in predicting follicular variant of papillary thyroid carcinoma. 25648502

2015

Entrez Id: 3265
Gene Symbol: HRAS
HRAS
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.340 SomaticCausalMutation ORPHANET RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma. 25109485

2015

Entrez Id: 3265
Gene Symbol: HRAS
HRAS
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.340 AlteredExpression BEFREE Mutation in BRAF exon 15, KRAS, NRAS, and HRAS were studied by polymerase chain reaction (PCR)-sequencing of tumor DNA; RET/PTC rearrangement was determined by reverse transcription (RT)-PCR-sequencing of tumor cDNA. 24798740

2014

Entrez Id: 3265
Gene Symbol: HRAS
HRAS
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.340 SomaticCausalMutation ORPHANET Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics. 25132659

2014

Entrez Id: 3265
Gene Symbol: HRAS
HRAS
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.340 GeneticVariation BEFREE The following molecular mutations were identified: BRAF (V600E) (n = 2), PAX8/PPARγ (n = 1), HRAS (n = 1), and RET/PTC (n = 1). 23993207

2013

Entrez Id: 3265
Gene Symbol: HRAS
HRAS
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.340 GeneticVariation BEFREE Twenty-five PTCs (11 with BRAF(V600E), 4 with RET/PTC1, and 10 without mutation in HRAS, KRAS, NRAS, BRAF, RET/PTC1, or RET/PTC3) were analyzed using Genome-Wide Human SNP Array 6.0 which allows us to detect copy number alteration (CNA) and uniparental disomy (UPD), also referred to as copy neutral loss of heterozygosity, in a single experiment. 22558328

2012

Entrez Id: 3265
Gene Symbol: HRAS
HRAS
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.340 AlteredExpression BEFREE Finally, KRAS2 was found to be differentially expressed (P<0.05) when comparing the papillary thyroid carcinoma and follicular thyroid carcinoma groups. 17660800

2007

Entrez Id: 3265
Gene Symbol: HRAS
HRAS
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.340 SomaticCausalMutation ORPHANET Molecular genetics of papillary thyroid carcinoma: great expectations. 17891228

2007